Literature DB >> 30853830

Biofilm biology and vaccine strategies for otitis media due to nontypeable Haemophilus influenzae.

Laura A Novotny1, Kenneth L Brockman1, Elaine M Mokrzan1, Joseph A Jurcisek1, Lauren O Bakaletz1.   

Abstract

Otitis media (OM) is one of the most common diseases of childhood, and nontypeable Haemophilus influenzae (NTHI) is the predominant causative agent of chronic and recurrent OM, as well as OM for which treatment has failed. Moreover, NTHI is now as important a causative agent of acute OM as the pneumococcus. NTHI colonizes the human nasopharynx asymptomatically. However, upon perturbation of the innate and physical defenses of the airway by upper respiratory tract viral infection, NTHI can replicate, ascend the Eustachian tube, gain access to the normally sterile middle ear space, and cause disease. Bacterial biofilms within the middle ear, including those formed by NTHI, contribute to the chronic and recurrent nature of this disease. These multicomponent structures are highly resistant to clearance by host defenses and elimination by traditional antimicrobial therapies. Herein, we review several strategies utilized by NTHI in order to persist within the human host and interventions currently under investigation to prevent and/or resolve NTHI-induced diseases of the middle ear and uppermost airway.

Entities:  

Keywords:  DNABII proteins; EPS; PilA; Type IV pilus; eDNA; integration host factor; phasevarion

Year:  2018        PMID: 30853830      PMCID: PMC6402341          DOI: 10.1055/s-0038-1660818

Source DB:  PubMed          Journal:  J Pediatr Infect Dis        ISSN: 1305-7707            Impact factor:   0.293


  114 in total

1.  Temperature profile in the nasal cavity.

Authors:  T Keck; R Leiacker; H Riechelmann; G Rettinger
Journal:  Laryngoscope       Date:  2000-04       Impact factor: 3.325

2.  The histone-like protein HU binds specifically to DNA recombination and repair intermediates.

Authors:  D Kamashev; J Rouviere-Yaniv
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

3.  Extracellular DNA required for bacterial biofilm formation.

Authors:  Cynthia B Whitchurch; Tim Tolker-Nielsen; Paula C Ragas; John S Mattick
Journal:  Science       Date:  2002-02-22       Impact factor: 47.728

4.  [pH of fluid collected from middle ear in the course of otitis media in children].

Authors:  M T Wezyk; A Makowski
Journal:  Otolaryngol Pol       Date:  2000

Review 5.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

Review 6.  The 500 Dalton rule for the skin penetration of chemical compounds and drugs.

Authors:  J D Bos; M M Meinardi
Journal:  Exp Dermatol       Date:  2000-06       Impact factor: 3.960

Review 7.  Otitis media: the chinchilla model.

Authors:  G S Giebink
Journal:  Microb Drug Resist       Date:  1999       Impact factor: 3.431

8.  Detection and characterization of pediatric serum antibody to the OMP P5-homologous adhesin of nontypeable Haemophilus influenzae during acute otitis media.

Authors:  Laura A Novotny; Michael E Pichichero; Philippe A Denoël; Cecil Neyt; Sylvie Vanderschrick; Guy Dequesne; Lauren O Bakaletz
Journal:  Vaccine       Date:  2002-10-04       Impact factor: 3.641

9.  Epitope mapping of the outer membrane protein P5-homologous fimbrin adhesin of nontypeable Haemophilus influenzae.

Authors:  L A Novotny; J A Jurcisek; M E Pichichero; L O Bakaletz
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

Review 10.  Respiratory infections caused by non-typeable Haemophilus influenzae.

Authors:  Timothy F Murphy
Journal:  Curr Opin Infect Dis       Date:  2003-04       Impact factor: 4.915

View more
  7 in total

Review 1.  Translating Recent Microbiome Insights in Otitis Media into Probiotic Strategies.

Authors:  Marianne F L van den Broek; Ilke De Boeck; Filip Kiekens; An Boudewyns; Olivier M Vanderveken; Sarah Lebeer
Journal:  Clin Microbiol Rev       Date:  2019-07-03       Impact factor: 26.132

2.  Induction of Mucosal IgA-Mediated Protective Immunity Against Nontypeable Haemophilus influenzae Infection by a Cationic Nanogel-Based P6 Nasal Vaccine.

Authors:  Rika Nakahashi-Ouchida; Hiromi Mori; Yoshikazu Yuki; Shingo Umemoto; Takashi Hirano; Yohei Uchida; Tomonori Machita; Tomoyuki Yamanoue; Shin-Ichi Sawada; Masashi Suzuki; Kohtaro Fujihashi; Kazunari Akiyoshi; Yuichi Kurono; Hiroshi Kiyono
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

3.  A Humanized Monoclonal Antibody Potentiates Killing of Diverse Biofilm-Forming Respiratory Tract Pathogens by Antibiotics.

Authors:  Nikola Kurbatfinski; Steven D Goodman; Lauren O Bakaletz
Journal:  Antimicrob Agents Chemother       Date:  2022-01-10       Impact factor: 5.938

4.  Expression of the Nontypeable Haemophilus influenzae Type IV Pilus Is Stimulated by Coculture with Host Respiratory Tract Epithelial Cells.

Authors:  Elaine M Mokrzan; Taylor J Johnson; Lauren O Bakaletz
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

Review 5.  Panel 8: Vaccines and immunology.

Authors:  Mark R Alderson; Tim Murphy; Stephen I Pelton; Laura A Novotny; Laura L Hammitt; Arwa Kurabi; Jian-Dong Li; Ruth B Thornton; Lea-Ann S Kirkham
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2019-12-18       Impact factor: 1.675

6.  Reprioritization of biofilm metabolism is associated with nutrient adaptation and long-term survival of Haemophilus influenzae.

Authors:  Alistair Harrison; Rachael L Hardison; Rachel M Wallace; James Fitch; Derek R Heimlich; Meghan O' Bryan; Laura Dubois; Lisa St John-Williams; Robert P Sebra; Peter White; M Arthur Moseley; J Will Thompson; Sheryl S Justice; Kevin M Mason
Journal:  NPJ Biofilms Microbiomes       Date:  2019-11-05       Impact factor: 7.290

7.  Characterization of the Phase-Variable Autotransporter Lav Reveals a Role in Host Cell Adherence and Biofilm Formation in Nontypeable Haemophilus influenzae.

Authors:  Zachary N Phillips; Preeti Garai; Greg Tram; Gael Martin; Annelies Van Den Bergh; Asma-Ul Husna; Megan Staples; Keith Grimwood; Amy V Jennison; Patrice Guillon; Mark von Itzstein; Michael P Jennings; Kenneth L Brockman; John M Atack
Journal:  Infect Immun       Date:  2022-03-08       Impact factor: 3.609

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.